News

SBRI – AI supporting early detection and diagnosis in heart failure management

Published on: 04/11/2020

SBRI – AI supporting early detection and diagnosis in heart failure management
AI, Funding
Member News, Funding news

Organisations can apply for a share of £120,000 inclusive of VAT, to develop an AI tool to provide accessible heart failure data from routine patient information.

  • Competition opens: Monday 12 October 2020
  • Competition closes: Wednesday 9 December 2020 11:00am

Description

This is a Small Business Research Initiative (SBRI) competition funded by NHS Scotland. Successful applicants will receive 100% funding and have access to advice from NHS Tayside, NHS Greater Glasgow and Clyde Health Board and the University of Dundee Health Informatics Centre.

The aim of this competition is to develop a system that can provide accessible, timely and accurate data on heart failure from healthcare information which is routinely collected in primary and secondary care.

We are looking for digital and data-driven partners to work with clinical and informatics experts in Tayside.

Together they will develop a solution to automatically evaluate and accurately extract meaningful data from a number of healthcare data sources, such as:

  • image
  • quantitative
  • unformatted text

The output will be a national dashboard to give clinicians, managers and policymakers timely access to data so that they can manage, develop or improve patient care.

This is phase 1 of a potential 2-phase competition. A decision to proceed with phase 2 will depend on the outcomes from phase 1 and assessment of a separate application into a subsequent phase 2 competition.

Only successful applicants from phase 1 will be able to apply to take part in phase 2.

Phase 1: research and development contracts, feasibility study

The first phase involves research and development (R&D) contracts being awarded to demonstrate technical feasibility of the proposed solution. A total of up to £40,000 inclusive of VAT, is allocated to this phase.

Feasibility study R&D contracts will be up to £10,000 inclusive of VAT. This is for each project for up to 3 months.

We expect to fund up to 4 projects. The assessors will consider fair value in making their evaluation.

We would welcome bids from a single entity that bring together sector specialists

Phase 2: research and development contracts, prototype development and testing

The second phase will involve up to 2 R&D contracts being awarded to businesses chosen from the successful phase 1 applicants. Up to £40,000 inclusive of VAT, will be allocated for each contract, in order to develop a prototype and undertake field testing for up to 15 months.

The contract is completed at the end of phase 2, and the successful business is expected to pursue commercialisation of their solution.

Any adoption and implementation of a solution from this competition would be the subject of a separate, possibly competitive, procurement exercise. This competition does not cover the purchase of any solution.

In applying to this competition you are entering into a competitive process. This competition closes at 11am UK time on the date of the deadline.

Funding type

Procurement

Project size

Phase 1 projects to range in size up to total costs of £10,000 inclusive of VAT.

NEWS​

Related News

New Round Tables announced to drive progress on EHDS and health AI

3 Jul 2025

The European Accessibility Act Is Here. Are You Ready?

2 Jul 2025
Why inclusive design is no longer optional – and how Big Motive can help you lead the way.

DTH-Lab Director: The G7 must act now to address the digital health transformation

2 Jul 2025
As digital platforms increasingly shape health systems and information flows, the G7 must lead in setting global standards to ensure safety, equity an...

InnoHSupport Open Calls

1 Jul 2025
Welcome to the InnoHSupport Open Calls!

Transformative Health Instrument Call 2025

1 Jul 2025
Apply to the Transformative Health Instrument (THI) Call 2025 if you are a growing and innovative healthcare start-up working on solutions that have s...

Longitude Prize on ALS

1 Jul 2025
The £7.5 million (~$10 million) Longitude Prize on ALS incentivises the use of AI-based approaches to transform drug discovery for amyotrophic lateral...

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *